OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
November 18, 2021
Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.
November 02, 2021
The adoption of perfusion cell culture continues to advance with the help of PAT tools.
October 02, 2021
Large-scale single-use bioreactors prove successful as limits are tested.
October 01, 2021
SUB bioreactor performance has had seen its limits and successes.
September 16, 2021
CPC’s MicroCNX Series Connectors provide an alternative to tube welding at small tubing sizes.
September 02, 2021
Advancements in bioprocessing technologies test microbial fermentation adaptability.
August 18, 2021
BlackBerry’s QNX real-time operating system may create cybersecurity vulnerabilities, according to FDA.
July 01, 2021
The acquisition of Intermountain Life Sciences will double Cytiva’s capacity for buffers and liquid cell culture media at its manufacturing site in Logan, Utah.
June 02, 2021
Cell-free expression is promising in preclinical applications, but still presents challenges to scale up for commercial production.
May 02, 2021
Demand for recombinant microorganism-based cell culture supplements is rising on the back of lower contamination risk.